Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group (Q42275364)
Jump to navigation
Jump to search
scientific article published on January 1, 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group |
scientific article published on January 1, 1994 |
Statements
1 reference
Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group (English)
1 reference
B. J. Hansen
J. Nordling
H. J. Mensink
S. Walter
1 January 1994
1 reference
1 reference
157
1 reference
169-176
1 reference
Identifiers
1 reference